Will Perrigo’s Glaxo Buy Make It Too Pricey?

By | June 2, 2015

Scalper1 News

Embattled generic drugmaker Perrigo (PRGO) agreed to buy a portfolio of over-the-counter drugs from GlaxoSmithKline (GSK) Tuesday, in a move some interpreted as helping it fend off the advances of Mylan (MYL). For an undisclosed sum, Perrigo agreed to acquire a variety of products including cold and flu medicines, nicotine patches and cold-sore treatments, whose sales totaled $110 million last year largely in European markets. Glaxo, for its part, Scalper1 News

Scalper1 News